|
HS Code |
852259 |
| Generic Name | Ofloxacin |
| Drug Class | Fluoroquinolone antibiotic |
| Mechanism Of Action | Inhibits DNA gyrase and topoisomerase IV |
| Indications | Bacterial infections (respiratory, urinary tract, skin, eye, etc.) |
| Route Of Administration | Oral, intravenous, ophthalmic |
| Common Brand Names | Floxin, Ocuflox |
| Pregnancy Category | Category C (use only if clearly needed) |
| Side Effects | Nausea, diarrhea, headache, dizziness, insomnia |
| Contraindications | Hypersensitivity to quinolones |
| Metabolism | Hepatic (liver) |
| Elimination Half Life | 4–5 hours |
| Excretion | Renal (primarily via urine) |
| Approval Status | FDA approved |
As an accredited Ofloxacin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ofloxacin comes in a white and blue blister pack, containing 10 film-coated tablets of 400 mg each, clearly labeled. |
| Shipping | Ofloxacin is typically shipped as a pharmaceutical-grade chemical in accordance with international regulations. It is securely packaged in sealed, clearly labeled containers to prevent contamination and degradation. Temperature and light control may be required, with documentation such as Material Safety Data Sheets (MSDS) and handling instructions included for safe transport and delivery. |
| Storage | Ofloxacin should be stored in a tightly closed container at room temperature, typically between 20°C to 25°C (68°F to 77°F), away from excessive heat, moisture, and direct light. It must be kept out of reach of children and pets. Avoid storing in the bathroom or near the sink to prevent exposure to moisture, which can degrade the medication's effectiveness. |
|
Purity 99%: Ofloxacin with purity 99% is used in pharmaceutical formulations, where it ensures consistent therapeutic efficacy and reduced risk of impurities. Particle Size <10 μm: Ofloxacin with particle size below 10 μm is used in ophthalmic suspensions, where it enhances ocular absorption and bioavailability. Stability Temperature 25°C: Ofloxacin stable at 25°C is used in hospital pharmacies, where it maintains potency during room temperature storage. Hydrate Form: Ofloxacin in hydrate form is used in intravenous solutions, where it improves solubility and rapid preparation for clinical administration. Melting Point 276°C: Ofloxacin with a melting point of 276°C is used in high-temperature sterilization processes, where it retains chemical integrity and therapeutic activity. Solubility in Water 30 mg/mL: Ofloxacin with solubility in water of 30 mg/mL is used in oral liquid formulations, where it allows accurate dosing and effective patient administration. Assay ≥98.5%: Ofloxacin with assay value ≥98.5% is used in tablet manufacturing, where it guarantees precise active ingredient content for dose uniformity. pH 6.0–8.0 (1% solution): Ofloxacin with pH 6.0–8.0 in 1% solution is used in injectable preparations, where it prevents injection site irritation and enhances patient comfort. Low Microbial Limit: Ofloxacin with a low microbial limit is used in sterile manufacturing environments, where it minimizes contamination risk and ensures patient safety. Optical Rotation -121° to -129°: Ofloxacin with optical rotation -121° to -129° is used in quality control testing, where it confirms product identity and enantiomeric purity. |
Competitive Ofloxacin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Antibiotic resistance isn’t an abstract future anymore. In clinics and pharmacies across the globe, doctors and pharmacists run into cases where standard antibiotic routines fail to do their job. This challenge pushes healthcare professionals and patients to search for compounds with a proven record, reliable absorption, and clear safety data. Ofloxacin stands as a practical answer in situations where widespread resistance worries both prescribers and families. Unlike the older antibiotics, it belongs to the fluoroquinolone class and treats a wide spectrum of bacterial infections. Anyone browsing a pharmacy shelf or speaking to a doctor about next-step therapy for stubborn infections might quickly recognize Ofloxacin’s reputation.
From time spent alongside hospital physicians and patients, I’ve noticed recurring confidence in Ofloxacin’s ability to tackle tough infections. Instead of only targeting a handful of organisms, it shows strong action against bacteria that strike the urinary tract, respiratory tract, skin, and even eyes. Ofloxacin gets prescribed in both oral and topical forms—offering flexibility. Available as tablets, eye drops, and sometimes ear drops, it suits people who can’t easily swallow pills or need fast local relief. Oral tablets usually come in 200 mg or 400 mg strengths, allowing dosing that matches the severity and type of infection.
This isn’t a mystery pill shrouded in marketing. Decades of real-world use have taught physicians when Ofloxacin deserves a spot in therapy and when to try other approaches. Clinical guidelines point to it as a trusted option, especially in community-acquired pneumonia, complicated urinary tract infections, and certain sexually transmitted diseases. It also steps in when resistance to older agents like ampicillin or trimethoprim-sulfamethoxazole turns infections stubborn.
In the world of antibacterials, differences in absorption and tissue penetration matter. Oral Ofloxacin tablets begin working soon after swallowing, which means patients living far from hospitals can start therapy at home. Rapid absorption into the bloodstream proves crucial during times when getting to a doctor takes hours or days. Ofloxacin’s wide tissue distribution translates to higher drug levels at the sites where bacteria hide.
For doctors regularly treating urinary tract infections, it’s clear that Ofloxacin clears infections faster than narrow-spectrum antibiotics because it covers both gram-negative and some gram-positive pathogens. In real patient care, that translates to fewer trips to the lab and less waiting for cultures. Where a medication like amoxicillin might need lab confirmation for sensitivity, Ofloxacin already covers typical pathogens. Terrestrial bacteria—like Escherichia coli or Pseudomonas species—often run into a wall when confronted by this drug.
Unlike macrolides or beta-lactams, Ofloxacin sidesteps common cross-allergies. Throughout years spent counseling patients, I’ve heard relief in the voices of those who finally found an antibiotic they could tolerate after rashes or reactions to penicillins. The fluoroquinolone structure avoids the beta-lactam ring, a culprit behind many allergic reactions in other antibiotics.
Ofloxacin achieves a balance that clinicians value: strength against tough bacteria and a lower chance of causing classic side effects tied to other classes. In hospitals, physicians watch for C. difficile colitis or kidney toxicity when prescribing multiple antibiotics, but Ofloxacin emerges as a workhorse with fewer gastrointestinal complaints than older therapies. Its broad action allows shorter and more simplified treatment courses, which means quicker recovery times for most people.
In a world shifting toward outpatient care, medications need to be convenient for people juggling family, employment, and real-life pressures. The oral form enables people to return home and manage therapy themselves, freeing up valuable hospital beds. That matters in rural clinics with limited space and staff. Parents with children suffering from conjunctivitis or middle ear infections find relief with easy-to-administer drops. From a personal perspective, I’ve seen busy parents prefer Ofloxacin for their kids due to the straightforward dosing and lack of complicated mixing routines required by some suspensions.
Look for Ofloxacin on the pharmacy shelf and you’ll encounter a clear trend toward usability. Tablets are often scored for easy splitting if dose adjustments are needed. A typical foil or plastic blister pack keeps the medication safe from humidity and contamination. The eye drops and ear drops appear in small, securely capped bottles with precise droppers. Patients appreciate the see-through liquid, which makes it easier to measure—and to see if an unusual color hints at contamination.
Pharmacies stock Ofloxacin under well-recognized brands, but generic labeling keeps it affordable and within reach of most families. Accessibility lifts a medication from theoretical usefulness to everyday relevance. Insurance plans, both public and private, typically include Ofloxacin, easing cost concerns for many. That practical reach matches the needs of populations seeing a spike in resistant infections, like elderly communities with chronic urinary tract problems or working adults exposed to community-acquired pneumonia.
Rather than insisting on four-times-daily regimens, Ofloxacin usually fits a twice-daily dosing schedule for tablet forms. Outpatients juggling full-time jobs or long commutes find this welcomed—no reminders buzzing every few hours. For drops, patients use them several times a day, depending on severity, which hospital nurses frame as more tolerable than the intense hourly drops some older therapies demand. The clarity and simplicity make compliance easier and reduce accidental missed doses.
Doctors advise completing the full course, even if symptoms fade early on, in order to prevent recurrence and resistance. From both a personal and professional angle, it’s satisfying to watch patients complete their course without complaints about side effects or dosing fatigue—something that happens often with less forgiving regimens.
People sometimes hear terms like “second generation fluoroquinolone” and wonder what distinction matters in daily life. Compared to older antibiotics like tetracyclines, Ofloxacin sidesteps tricky dietary restrictions—no need to skip dairy at every meal or wait hours after taking the pill. Gastrointestinal upset, often associated with erythromycin or some cephalosporins, presents less frequently.
Other fluoroquinolones, such as ciprofloxacin or levofloxacin, might get prescribed in related situations. Ofloxacin stands out because of its balance between safety and convenience. Where ciprofloxacin needs special caution with some nerve-related side effects, Ofloxacin rarely causes confusion or hallucinations. Some colleagues remark that Ofloxacin’s profile in elderly patients matches well with daily routines—reducing the risk of drug-drug interactions seen with other quinolones.
Unlike aminoglycosides, which require close drug level monitoring and sometimes hospitalization for intravenous dosing, Ofloxacin’s oral form works well for uncomplicated cases. For patients dreading injections or those on home therapy, this distinction tilts the scale toward oral Ofloxacin.
No medicine avoids drawbacks. Clinicians and patients need to weigh potential side effects, especially with the backdrop of the ongoing global push for careful antibiotic use. Joint pain, and—rarely—tendon rupture have appeared in those with existing tendon disorders or in older adults. It’s wise to stick to official guidelines and avoid using Ofloxacin for trivial or viral illnesses. Responsible prescribing preserves effectiveness for future generations.
Microbial resistance continues to pose a threat: medical journals note increasing resistance patterns in certain regions, especially where antibiotics get dispensed without oversight. Those involved in antibiotic stewardship integrate Ofloxacin into rotation plans, decreasing the chance that bacteria adapt permanently. During hospital rounds, infection control teams stress the value of matching the right drug to the right bug—a practice that makes a difference in outcomes and preserves this tool for those who need it most.
For pregnant or breastfeeding individuals, as well as young children, doctors recommend caution. While Ofloxacin appears effective, sufficient studies in these groups haven’t painted a full safety picture. Physicians often turn to older, better studied antibiotics in these cases.
Changing patterns in bacterial resistance mean that Ofloxacin cannot stand alone. Hospitals, clinics, and pharmacies now incorporate stewardship programs, tracking antibiotic use and passing along data about resistance trends. This collective record-keeping leads to smarter therapy choices, preventing the exhaustion of drugs that still work.
Many patients, understandably, seek antibiotics as a quick fix for coughs or fevers. Nurses and pharmacists play a key role, taking time to explain viral versus bacterial indications. Personal experience supports the impact of clear education: when people grasp why a drug is reserved for certain cases, requests for unnecessary prescriptions drop meaningfully. Ofloxacin thrives in this type of environment—employed by professionals who understand its strengths and seek to guard its utility.
Emerging research encourages tailoring therapy with culture and sensitivity results. For those in rural or under-resourced settings, collaboration with regional labs—sometimes via telemedicine—ensures Ofloxacin finds its place strategically, not simply by guesswork. This practice helps ensure no one finds themselves out of options when truly needed.
Spending years among patients and medical teams attunes you to the reality that convenience, reliability, and affordability drive many real-world health decisions. Ofloxacin brings those strengths to the table, earning its standing as a go-to medication in the antimicrobial toolkit. Clear dosing, multiple forms, and demonstrated activity against a wide range of infections mark it as a choice people trust. Unlike old-fashioned products with more cumbersome routines or limited bacterial profiles, Ofloxacin readily matches modern health demands—short courses, home therapy, and fewer dietary constraints.
Doctors, nurses, and patients share responsibility for preserving this valuable remedy. Through informed use, ongoing education, and adaptation based on resistance trends, Ofloxacin keeps serving as a frontline defense across hospitals, clinics, and pharmacies. Its story reflects the ongoing partnership between medical progress and everyday practical needs—one that requires vigilance and respect well into the future.